Disturbed CXCR4/CXCL12 axis in paediatric precursor B-cell acute lymphoblastic leukaemia. (Q53583157)

15 May 2018

title

Disturbed CXCR4/CXCL12 axis in paediatric precursor B-cell acute lymphoblastic leukaemia. (English)

1 reference

15 May 2018

1 reference

9

Monique L den Boer

1 reference

15 May 2018

Rob Pieters

8

object named as

Rob Pieters

1 reference

15 May 2018

Lieke C J van den Berk

1

1 reference

15 May 2018

Arian van der Veer

2

1 reference

15 May 2018

Marieke E Willemse

3

1 reference

15 May 2018

Myrte J G A Theeuwes

4

1 reference

15 May 2018

Mirjam W Luijendijk

5

1 reference

15 May 2018

Wing H Tong

6

1 reference

15 May 2018

Inge M van der Sluis

7

1 reference

15 May 2018

language of work or name

English

0 references

publication date

4 April 2014

1 reference

15 May 2018

British Journal of Haematology

published in

1 reference

15 May 2018

volume

166

1 reference

15 May 2018

page(s)

240-249

1 reference

15 May 2018

issue

2

1 reference

15 May 2018

Effects of the chemokine stromal cell-derived factor-1 on the migration and localization of precursor-B acute lymphoblastic leukemia cells within bone marrow stromal layers.

cites work

1 reference

CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment

21 January 2018

1 reference

Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1

21 January 2018

1 reference

Leukemic cells create bone marrow niches that disrupt the behavior of normal hematopoietic progenitor cells

21 January 2018

1 reference

High expression of the chemokine receptor CXCR4 predicts extramedullary organ infiltration in childhood acute lymphoblastic leukaemia.

21 January 2018

1 reference

Patient stratification based on prednisolone-vincristine-asparaginase resistance profiles in children with acute lymphoblastic leukemia

21 January 2018

1 reference

Phase III prospective randomized double-blind placebo-controlled trial of plerixafor plus granulocyte colony-stimulating factor compared with placebo plus granulocyte colony-stimulating factor for autologous stem-cell mobilization and transplantatio

21 January 2018

1 reference

CXCL12 polymorphism and malignant cell dissemination/tissue infiltration in acute myeloid leukemia.

21 January 2018

1 reference

Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region.

21 January 2018

1 reference

G-CSF down-regulation of CXCR4 expression identified as a mechanism for mobilization of myeloid cells

21 January 2018

1 reference

The leukemic stem cell niche: current concepts and therapeutic opportunities

21 January 2018

1 reference

The haematopoietic stem cell niche: new insights into the mechanisms regulating haematopoietic stem cell behaviour

21 January 2018

1 reference

Effect of priming with granulocyte colony-stimulating factor on the outcome of chemotherapy for acute myeloid leukemia

21 January 2018

1 reference

The bone marrow microenvironment as a tumor sanctuary and contributor to drug resistance

21 January 2018

1 reference

Environment-mediated drug resistance: a major contributor to minimal residual disease

21 January 2018

1 reference

Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100.

21 January 2018

1 reference

The hematopoietic stem cell niche.

21 January 2018

1 reference

Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front

21 January 2018

1 reference

Phosphoprotein pathway mapping: Akt/mammalian target of rapamycin activation is negatively associated with childhood rhabdomyosarcoma survival

21 January 2018

1 reference

Acute B lymphoblastic leukaemia-propagating cells are present at high frequency in diverse lymphoblast populations

21 January 2018

1 reference

Relation between CXCR-4 expression, Flt3 mutations, and unfavorable prognosis of adult acute myeloid leukemia

21 January 2018

1 reference

The chemokine receptor CXCR4 enhances integrin-mediated in vitro adhesion and facilitates engraftment of leukemic precursor-B cells in the bone marrow.

21 January 2018

1 reference

In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment

21 January 2018

1 reference

CXCR4 is a prognostic marker in acute myelogenous leukemia.

21 January 2018

1 reference

Prognostic value of CXCR4 and FAK expression in acute myelogenous leukemia.

21 January 2018

1 reference

CXCL12 (SDF-1)/CXCR4 pathway in cancer

21 January 2018

1 reference

A meta-analysis of CAG (cytarabine, aclarubicin, G-CSF) regimen for the treatment of 1029 patients with acute myeloid leukemia and myelodysplastic syndrome

21 January 2018

1 reference

Targeting the leukemia microenvironment by CXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML.

21 January 2018

1 reference

NOTCH1 and/or FBXW7 mutations predict for initial good prednisone response but not for improved outcome in pediatric T-cell acute lymphoblastic leukemia patients treated on DCOG or COALL protocols

21 January 2018

1 reference

Plerixafor: AMD 3100, AMD3100, JM 3100, SDZ SID 791

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/BJH.12883

1 reference

15 May 2018

PubMed ID

24697337

1 reference

15 May 2018